The North America water for injection market is projected to grow from over USD 13.3 billion in 2025 to approximately USD 31.78 billion by 2035, registering a robust CAGR of 9.10%, driven by rising pharmaceutical manufacturing, growing injectable drug demand, and expansion of healthcare infrastructure.

North America Water For Injection Market Statical Scope

Due to rising demand form, pharmaceutical, and biotechnology industries, it is widely used in sterile drug manufacturing, and injectable formulations, across hospital and labs. It includes growing adoption of high- purity water system, increasing regulatory standards, ensuring safety and quality expansion, of biologics production and hospital infrastructure, for the driving market growth across the region rapidly.

Advanced purification technologies, such as reverse osmosis distillation, and ultrafiltration, are widely used to produce water for injection automation continuous monitoring, and single- use systems art improving efficiency, and reducing contamination risk significantly today globally.

North America Water For Injection Market Share, By Application, 2025 (%)

• Formulate Parenteral Drugs-The segment dominated the market with a 64% share, due to high demand for sterile injectables, strict safety standards, and strong pharmaceutical manufacturing activity.
• Solvent- The segment accounted for 23% of the total market share, because it ensures high purity, save drug dissolution, and comprehensive with strict pharmaceutical manufacturing standards.
• Cleaning Agents- The segment accounted for 13% of the total market share, due to its high purity, ensuring effective sterilisation and preventing contamination in pharmaceutical equipment and production facilities.

North America Water For Injection Market Share, By End-User, 2025 (%)

• Pharmaceutical and Biotechnology Companies-The segment dominated the market with a 72% share, due to large- scale sterile drug production, biologics growth, and strict regulatory quality requirements.
• Research Institutes- The segment accounted for 16% of the total market share, because it is essential for sterile lab experiments, drug research, and maintaining high- purity conditions in biomedical studies.
• Others- The segment accounted for 12% of the total market share, due to its use in hospitals, contract manufacturing, and smaller healthcare facilities requiring sterile water supply.

Top Companies in the North America Water For Injection Market

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Eurocrit Labs International
• Evoqua Water Technologies
• Veolia Water Solutions and Technologies
• ICU Medical Inc.
• Danaher Corporation (Cytiva)
• Rocky Mountain Biologicals
• B. Braun Melsungen AG
• SteriCare Solutions
• Veltek Associates, Inc.

Segments Covered in the Report

By Application

• Formulate Parental Drugs
• Solvent
• Cleaning Agents

By End-user

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• Others